334 - Efficacy, Safety, and Completion of Modified Short-Course Rifapentine and Isoniazid for Latent Tuberculosis Infection in High-Risk Patients with Rheumatic Disease: A Multicenter Randomized Controlled Trial

Presenting Author(s)

• 

  lifan zhang, MD

  Associate researcher
  Peking Union Medical College Hospital,
  Beijing, Beijing, China

Co-Author(s)

• yh

  yujie he, n/a

  The First Affiliated Hospital of Zhengzhou University
  Zhengzhou, Hainan, China
• ww

  wenwen wang, n/a

  The Second Affiliated Hospital of Zhejiang University School of Medicine
  Hangzhou, Zhejiang, China
• lw

  lijun wu, n/a

  People’s Hospital of Xinjiang Uygur Autonomous Region
  Urumchi, Xinjiang, China
• xz

  xiaoxia zuo, n/a

  Xiangya Hospital, Central South University
  Changsha, Hunan, China
• sc

  sheng chen, n/a

  Renji Hospital, School of Medicine, Shanghai Jiao Tong University
  Shanghai, Shanghai, China
• yz

  yanping zhao, n/a

  The First Affiliated Hospital of Harbin Medical University
  Harbin, Heilongjiang, China
• pz

  ping zhu, n/a

  Xijing Hospital, Fourth Military Medical University
  Xi’an, Shanxi, China
• hl

  hongbin li, n/a

  The Affiliated Hospital of Inner Mongolia Medical University
  Hohhot, Nei Mongol, China
• xl

  xiaoqing liu, n/a

  Peking Union Medical College Hospital
  Beijing, Beijing, China